Psycheceutical Bioscience, Inc. Announces Medical Advisory Board
October 18, 2022 10:15 ET
|
Psycheceutical Bioscience, Inc.
MIAMI, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc ("Psycheceutical" or the "Company") (OTC: BWVI), a bioscience company dedicated to developing cutting-edge technologies for...
Psycheceutical Bioscience, Inc.'s Zappy Zapolin Added to The Benzinga Psychedelics Advisory Council
October 04, 2022 10:14 ET
|
Psycheceutical Bioscience, Inc.
MIAMI, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc. (“Psycheceutical” or the “Company”) (OTC: BWVI), a bioscience company dedicated to developing cutting-edge technologies for...
Psycheceutical Bioscience, Inc.'s CEO to Present at the Life Sciences Investor Forum on September 15
September 13, 2022 11:15 ET
|
Psycheceutical Bioscience, Inc.
MIAMI, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc. ("Psycheceutical" or the "Company") (OTC: BWVI), a bioscience company dedicated to developing cutting-edge technologies for...
Psycheceutical Bioscience, Inc. Enters into Exclusive Option to Acquire Vici Health Sciences
August 16, 2022 10:14 ET
|
Psycheceutical Bioscience, Inc.
MIAMI, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc. (“Psycheceutical” or the “Company”) (OTC: BWVI), a bioscience company dedicated to developing cutting-edge technologies for...
Mydecine Provides Company Update; Welcomes New Board Member
June 09, 2022 07:00 ET
|
Mydecine Innovations Group Inc.
DENVER, June 09, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology company aiming to transform the...
CATALYST Summit 2022 Returns to Highlight Psychedelic Medicine’s Growing Role in the Medical Industry, Business Innovation and Society
May 05, 2022 06:30 ET
|
CATALYST Presents Foundation
Kingston, Ontario, May 05, 2022 (GLOBE NEWSWIRE) -- CATALYST Presents Foundation (“CATALYST”), the producer of Canada's premiere series of psychedelic medicine conferences, hosts its third annual...
CATALYST Summit 2022 Returns to Highlight Psychedelic Medicine’s Growing Role in the Medical Industry, Business Innovation and Society
May 05, 2022 06:30 ET
|
CATALYST Presents Foundation
Kingston, Ontario, May 05, 2022 (GLOBE NEWSWIRE) -- CATALYST Presents Foundation (“CATALYST”), the producer of Canada's premiere series of psychedelic medicine conferences, hosts its third annual...
Microdose Psychedelic Insights to Host Psychedelic Capital: March 2022 Conference
March 10, 2022 09:35 ET
|
Microdose Psychedelic Insights
TORONTO, March 10, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Microdose Psychedelic Insights, the leading guide to the business of psychedelics will be hosting the upcoming Psychedelic Capital:...
Ketamine Media Launches Industry-Leading Psychedelic Therapy Network
February 03, 2022 09:30 ET
|
Ketamine Media
KNOXVILLE, Tenn., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Ketamine Media (Keta Media, LLC) is proud to announce the launch of its Psychedelic Therapy Network (PTN), a digital ecosystem linking psychedelic...
IBN (InvestorBrandNetwork) and PsychedelicNewsWire to Further Collaborate with Microdose Psychedelic Insights for the Upcoming Wonderland Miami Conference
November 01, 2021 09:35 ET
|
InvestorBrandNetwork (IBN)
NEW YORK, Nov. 01, 2021 (GLOBE NEWSWIRE) -- via PsychedelicNewsWire -- IBN (“InvestorBrandNetwork”), a multifaceted financial news and publishing company, today announces that it will be...